Volume 62, Issue 11 pp. 2163-2171
HOW DO I DO IT

How do we improve blood product administration audit rates

Jessica L. Morrow

Jessica L. Morrow

Nurse Anesthesia Program, Duke University School of Nursing, Durham, North Carolina, USA

Search for more papers by this author
Jessica Szydlowski Pitman

Jessica Szydlowski Pitman

Nurse Anesthesia Program, Duke University School of Nursing, Durham, North Carolina, USA

Search for more papers by this author
Ryland Elliott

Ryland Elliott

Duke Nurse Anesthesiology Department, Durham, North Carolina, USA

Search for more papers by this author
Virginia C. Simmons

Corresponding Author

Virginia C. Simmons

Nurse Anesthesia Program, Duke University School of Nursing, Durham, North Carolina, USA

Correspondence

Virginia C. Simmons, Nurse Anesthesia Program, Duke University, 307 Trent Drive DUMC 3322, Durham, NC 27710, USA.

Email: [email protected]

Search for more papers by this author
First published: 12 September 2022

Abstract

Background

Failure to comply with institutional and national standards for blood product administration poses patient safety risks. Monitoring adherence to blood product administration policy is important for maintaining patient safety and ensuring regulatory agency compliance.

Study Design and Methods

This post-implementation quality improvement project evaluated an electronic paging system that was developed to facilitate perioperative blood product administration audits.

Results

Of the 57 audits conducted, 55 (96.5%) audits were fully completed. Anesthesia providers verified the patient name and medical record number (MRN) on the patient's armband with the product ID tag in 36.5% (n = 20) of audits. Anesthesia providers ensured the name and MRN on the armband matched the compatibility label on the blood product in 23% (n = 23) of audits.

Discussion

Ongoing surveillance of blood product administration practices is needed to monitor adherence to blood product administration policy, promote patient safety, and avoid imminent financial consequences from noncompliance to national regulatory standards.

CONFLICT OF INTEREST

The authors have disclosed no conflicts of interest.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.